mitomycin has been researched along with Corneal Dystrophy, Juvenile Epithelial of Meesmann in 2 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Corneal Dystrophy, Juvenile Epithelial of Meesmann: An autosomal dominant form of hereditary corneal dystrophy due to a defect in cornea-specific KERATIN formation. Mutations in the genes that encode KERATIN-3 and KERATIN-12 have been linked to this disorder.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ghanem, RC | 1 |
Piccinini, AL | 1 |
Ghanem, VC | 1 |
Yeung, JY | 1 |
Hodge, WG | 1 |
2 other studies available for mitomycin and Corneal Dystrophy, Juvenile Epithelial of Meesmann
Article | Year |
---|---|
Photorefractive Keratectomy With Mitomycin C in Meesmann's Epithelial Corneal Dystrophy.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Corneal Dystrophy, Juvenile Epithelial of Meesm | 2017 |
Recurrent Meesmann's corneal dystrophy: treatment with keratectomy and mitomycin C.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Corneal Dystrophy, Juvenile Epithelial of Meesm | 2009 |